Case Study: Treatment of Post-Prostate Removal Complications with coMra Therapy

Patient Information

• Age: 72 years old
• Gender: Male
• Condition: Side effects following prostate gland removal (January 2016)

Initial Symptoms

1. Recurrent urinary tract infections
2. Urinary incontinence (requiring padding)
3. Frequent urge to urinate with insufficient flow
4. Severe pelvic pain (8-9 out of 10 on pain scale)
5. Fatigue and sleep disturbances
6. Depression and hopelessness

Medical History

• Prostate gland removal in January 2016
• Multiple ER visits due to inability to urinate
• Diagnosed with possible urethra stricture
• Diagnosed with possible interstitial cystitis (IC)
• Urethral dilation procedure performed

coMra Treatment Protocol

• Device: 980 Delta (home use)
• Duration: Three months (with breaks)
• 1st month: June 1 - June 30
• 15-day break
• 2nd month: July 15 - August 15
• Break
• 3rd month: September
• Daily treatments:
• Urology 3 (for bladder inflammation)
• Urology 5 (for urinary incontinence)
• Universal 3 and 5 (alternating every other day for systemic support)

Additional Recommendations

• Dietary changes to reduce bladder irritation
• Removal of padding to encourage bladder training

Results After Treatment

1. No recurrence of urinary tract infections
2. Resolved difficulty in urinating
3. Pelvic pain reduced from 8 to 2 on the pain scale
4. Nighttime bathroom trips reduced by 60% (now 2 trips per night)
5. Improved sleep quality
6. Urinary incontinence only occurs with fatigue or high activity
7. Energy levels improved to 80%
8. Significant improvement in mood and outlook

Key Learnings

1. Patient cooperation and belief in self-healing is crucial for success
2. coMra therapy can address conditions deemed “incurable” by conventional medicine
3. A holistic approach, including dietary changes, can enhance treatment effectiveness

This case study demonstrates the potential of coMra therapy in treating complex urological issues following prostate removal, resulting in significant improvements in the patient’s quality of life and overall well-being.